Eledon Pharmaceuticals Inc (ELDN)
Operating Cash Flow (Statement)
-$73.86M
TTM · Period ending: · USD
ELDN Operating Cash Flow (Statement)
Latest reported-$73.86Mperiod ending
Latest reported-$73.86Mperiod ending
ELDN TTM Cash from Operations (-$21.12M → -$73.86M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ELDN operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -73,857,000 | |
| -68,893,000 | |
| -62,341,000 | |
| -67,237,000 | |
| -64,529,000 | |
| -54,590,000 | |
| -47,271,000 | |
| -37,415,000 | |
| -37,897,000 | |
| -38,344,000 | |
| -39,527,000 | |
| -39,876,000 | |
| -32,196,000 | |
| -30,192,000 | |
| -28,424,000 | |
| -28,152,000 | |
| -30,674,000 | |
| -31,903,000 | |
| -28,913,000 | |
| -29,138,000 | |
| -22,606,000 | |
| -18,181,000 | |
| -15,212,000 | |
| -7,802,000 | |
| -10,130,000 | |
| -12,031,000 | |
| -13,857,000 | |
| -15,187,000 | |
| -15,233,000 | |
| -13,645,000 | |
| -11,893,000 | |
| -11,151,000 | |
| -11,633,000 | |
| -14,064,000 | |
| -14,941,000 | |
| -19,640,000 | |
| -25,396,000 | |
| -29,928,000 | |
| -36,520,000 | |
| -38,087,000 | |
| -39,164,000 | |
| -39,872,000 | |
| -41,236,000 | |
| -38,819,000 | |
| -33,033,000 | |
| -27,449,000 | |
| -21,121,000 | |
| -21,482,000 | |
| -19,999,000 |